Effect of pharmacologic lipid lowering on health-related quality of life in older persons: Results from the Cholesterol Reduction in Seniors Program (CRISP) pilot study

Journal of the American Geriatrics Society

Volumn 45, Issue 1, 1997, Pages 8-14

  Santanello, Nancy C ^a   Barber, Beth L ^a   Applegate, William B ^b   Elam, Janet ^b   Curtis, Carolyn ^c   Hunninghake, Donald B ^e   Gordon, David J ^d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d Division of Cardiovascular Sciences NHLBI   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; FEMALE; HAIR LOSS; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYALGIA; PHYSICAL CAPACITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; SLEEP; SOCIAL SUPPORT; TRIACYLGLYCEROL BLOOD LEVEL; VISUAL DISORDER;

EID: 0031021211     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb00971.x     Document Type: Article

References (27)

1. Feinleib M, Gillum RF. Coronary heart disease in the elderly: the magnitude of the problem in the United States. In: Wenger NK, Furberg CD, Pitt E, eds. Coronary Heart Disease in the Elderly, Working Conference on the Recognition and Management of Coronary Heart Disease in the Elderly. New York: Elsevier, 1986:29-56.
2. Sempos CT, Cleeman JI, Carrol MD, Johnson CL, Bachork PS, Gordon DJ, Burt VL, Briefel RR, Brown CD, Lippel K, Rifkind BM. Prevalence of high blood cholesterol among US adults: an update based on guidelines from the Second Report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 1993;269(23):3009-3014.
3. Gordon DJ, Rifkind BM. Treating high blood cholesterol in the older patient. Am J Cardiol 1989;63(16):48H-52H.
4. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol 1992;2(1-2):161-76.
5. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344(8934):1383-89.
6. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel II). Circulation 1994 Mar;89(3):1333-445.
7. Bradford RH, Shear CL, Chremos AN, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins, an implication for managing patients with moderate hypercholesterolemia. Am J Med 1991;91(Suppl 1B):18S-24S.
8. Croog SH, Levine S, Testa MT, et al. The effects of antihypertensive therapy on quality of life. N Engl J Med 1986;314(26):1657-64.
9. Goldstein G, Materson BJ, Cushman WC, et al for the Department of Veterans Affairs Cooperative Study. Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. Hypertension 1990;15(4):361-369.
10. Applegate WB, Phillips HL, Schnaper H, Shepherd AMM, Schocken D, Luhr JC, Koch GC, Park GD. A randomized controlled trial of three antihypertensive agents on blood pressure control and quality of life in elderly females. Arch Intern Med, 1991;151(9):1817-1823.
11. Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, Greenlick, MR, Hadley E, Moye L, Perry HM Jr., Schron E, Wegener V, for the Systolic Hypertension in the Elderly Program Cooperative Research Group. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the Systolic Hypertension in the Elderly Program (SHEP) Study. Arch Intern Med, 1994;154(19):2154-60.
12. LaRosa JC, Applegate WB, Crouse JR, Hunninghake DB, Grimm R, Knopp R, Eckfeldt JH, Davis CE, Gordon DJ. Cholesterol lowering in the elderly: Results of the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study. Arch Intern Med. 1994;154(5):529-539.
13. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State'.a practical method for grading the cognitive state of patients for clinicians. J Psychiatr Res. 1975;12(3):189-198.
14. Rosow I, Breslau H. A Guttman health scale of the aged. J Gerontology 1966;21:556-559.
15. Katz S, Downs TD, Cash HR, et al. Progress in the development of an index of ADL. Gerontologist 1970;10(1):20-30.
16. Lawton MP. The functional assessment of elderly people. J Am Geriatr Soc. 1971;19(6):465-481.
17. National Center for Health Statistics, JE Fitti and MG Kovar. The Supplement on Aging to the 1984 National Health Interview Survey, Vital and Health Statistics. Series 1, No. 21. DHHS Pub. No. (PHS) 87-1323. Public Health Service. Washington. U.S. Government Printing Office. October 1987.
18. Rose RM, Jenkins CD, Hurst MW. Air Traffic Controller Health Change Study: A prospective investigation of physical, psychological, and work-related changes. A report to Federal Aviation Administration on research performed under Contract No. DOT FA73WA-3211. Boston, Mass: Boston University School of Medicine, August 1978. Document FAA-AM-78-39.
19. Heitzmann CA and Kaplan RM. Assessment of methods for measuring social support. Health Psychol. 1988;7(1):75-109.
20. Radloff LS The CES-D Scale. A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
21. Wechsler D. Manual for the Wechsler Adult Intelligence Scale (WAIS-R). New York, NY: Psychological Corp; 1955.
22. Andrews FM and Withey SB. Developing measures of perceived life quality: results from several national surveys. Social Indicator Research. 1974;Vol 1:1-26.
23. Tukey JW, Ciminera JL, Heyse JF. Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 1985;41:295-30.
24. Capizzi T, Survill TT, Heyse JF, Malani H. An empirical and simulated comparison of some tests for detecting progressiveness of response with increasing doses of a compound. 1992;Biometrical Journal 34:275-289.
25. Morgan RE, Palinkas LA, Barrett-Connor EL, Wingard, DL. Plasma cholesterol and depressive symptoms in older men. Lancet 1993;341:75-79.
26. Dealberto MJ, Duchimetiere P, Mainard F, and Alperovitch A. Serum lipids and depression. Letter to the Editor. Lancet. 1993;341:435.
27. Downs JR, Oster G, Santanello NC. HMG CoA reductase inhibitors and quality of life. Letter to the Editor. JAMA 1993 Jun 23-30; 269(24):3107-8.